Suppr超能文献

逍遥丸中自组装纳米乳剂的表征及其用于增强药物递送的释放与行为研究

Characterization and Release & Behavior Study of Self-Assembled Nano-Emulsion in XiaoYao Pill for Enhanced Drug Delivery.

作者信息

QingXia Guan, MeiWei Zhu, LianZhi Wang, ZhongXin Chen, FangFang Yang, ZhiPing Yang, XiaoFang Dai, FangYuan Zhao

机构信息

Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, 24 Heping Street, Xiangfang District, Harbin, 150040, Heilongjiang Province, China.

The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, 24 Heping Street, Xiangfang District, Harbin, 150040, Heilongjiang Province, China.

出版信息

Curr Drug Deliv. 2025;22(5):593-616. doi: 10.2174/0115672018303538240827102421.

Abstract

INTRODUCTION/BACKGROUND: Traditional Chinese medicine formulations often contain hydrophobic components with limited solubility and stability, leading to low oral bioavailability. Selfassembled nanoparticles (SANs) have shown promise in enhancing oral bioavailability of these components. However, whether un-decocted Chinese herbal pellets can generate SANs and the impact of SANs formed by multiple components on pharmacokinetic parameters remains unexplored.

METHODS

In this study, single-factor approach was employed to determine the optimal separation method of nano-emulsion phase of XiaoYao pill (N-XY). Morphological and particle size analyses confirmed the nanoscale nature of N-XY. High-performance liquid chromatography (HPLC) fingerprint analysis was conducted to compare the distribution of active ingredients among three different phases of XiaoYao pill (XY pill). release studies were performed to evaluate the release mechanism of four ingredients from N-XY. Additionally, pharmacokinetics and tissue distribution behaviors were investigated in rats.

RESULTS

N-XY exhibited uniform and stable characteristics as a water-in-oil (O/W) nano-emulsion. Fingerprint analysis identified 25 characteristic peaks and 8 key ingredients in N-XY, with the highest peak areas. release studies showed a sustained release behavior of N-XY. The pharmacokinetics study showed that the ferulic acid of N-XY had a 1.37-fold higher AUC, 1.44-fold lower , 1.39-fold lower , and a prolonged than A-XY, indicating enhanced bioavailability due to reduced elimination. Furthermore, the tissue distribution revealed that the levels of paeoniflorin and ferulic acid from N-XY significantly increased in liver, spleen, lungs, uterus and ovaries, exhibiting targeting characteristics.

CONCLUSION

This study comprehensively explored the formation, characterization, and pharmacokinetics of nano-emulsion in XY pill, introducing novel perspectives and initiating preliminary research on potential SANs in un-decocted traditional Chinese medicine formulations. It also emphasized the importance of enhancing pharmacokinetics of hydrophobic components in Chinese herbal formulations and laid the foundation for future nano-formulation research for XY pill.

摘要

引言/背景:中药制剂通常含有溶解度和稳定性有限的疏水性成分,导致口服生物利用度较低。自组装纳米颗粒(SANs)已显示出提高这些成分口服生物利用度的潜力。然而,未煎煮的中药丸剂是否能产生SANs以及多种成分形成的SANs对药代动力学参数的影响仍未得到探索。

方法

在本研究中,采用单因素法确定逍遥丸纳米乳相(N-XY)的最佳分离方法。形态学和粒径分析证实了N-XY的纳米级性质。进行高效液相色谱(HPLC)指纹图谱分析,以比较逍遥丸(XY丸)三个不同相之间活性成分的分布。进行释放研究以评估N-XY中四种成分的释放机制。此外,在大鼠中研究了药代动力学和组织分布行为。

结果

N-XY表现出水包油(O/W)纳米乳的均匀和稳定特性。指纹图谱分析确定了N-XY中的25个特征峰和8种关键成分,其峰面积最高。释放研究表明N-XY具有缓释行为。药代动力学研究表明,N-XY的阿魏酸AUC比A-XY高1.37倍,Cmax低1.44倍,Tmax低1.39倍,且t1/2延长,表明由于消除减少,生物利用度提高。此外,组织分布显示,N-XY中的芍药苷和阿魏酸在肝脏、脾脏、肺、子宫和卵巢中的水平显著增加,表现出靶向特征。

结论

本研究全面探索了XY丸中纳米乳的形成、表征和药代动力学,为未煎煮的中药制剂中潜在的SANs引入了新的视角并启动了初步研究。它还强调了提高中药制剂中疏水性成分药代动力学的重要性,并为未来XY丸的纳米制剂研究奠定了基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验